IN2013MU00665A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00665A
IN2013MU00665A IN665MU2013A IN2013MU00665A IN 2013MU00665 A IN2013MU00665 A IN 2013MU00665A IN 665MU2013 A IN665MU2013 A IN 665MU2013A IN 2013MU00665 A IN2013MU00665 A IN 2013MU00665A
Authority
IN
India
Prior art keywords
present
novel compounds
provides
oxalate
raloxifene
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivas Laxminarayan Pathi
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Chandrasekaran Ramasubbu
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN665MU2013 priority Critical patent/IN2013MU00665A/en
Priority to PCT/GB2014/000081 priority patent/WO2014135834A1/en
Priority to ZA2014/01636A priority patent/ZA201401636B/en
Publication of IN2013MU00665A publication Critical patent/IN2013MU00665A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN665MU2013 2013-03-05 2014-03-05 IN2013MU00665A (instruction)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (instruction) 2013-03-05 2014-03-05
PCT/GB2014/000081 WO2014135834A1 (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
ZA2014/01636A ZA201401636B (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (instruction) 2013-03-05 2014-03-05

Publications (1)

Publication Number Publication Date
IN2013MU00665A true IN2013MU00665A (instruction) 2015-07-03

Family

ID=50382470

Family Applications (1)

Application Number Title Priority Date Filing Date
IN665MU2013 IN2013MU00665A (instruction) 2013-03-05 2014-03-05

Country Status (3)

Country Link
IN (1) IN2013MU00665A (instruction)
WO (1) WO2014135834A1 (instruction)
ZA (1) ZA201401636B (instruction)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018521988A (ja) 2015-06-16 2018-08-09 ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． ピペリジン誘導体およびその製造方法および医薬用途
CN107428721B (zh) 2015-12-22 2020-07-28 江苏恒瑞医药股份有限公司 苯并哌啶类衍生物、其制备方法及其在医药上的应用
AU2021205156A1 (en) 2020-01-10 2022-07-14 Jiangsu Hengrui Medicine Co., Ltd. Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine
EP4368624A4 (en) 2021-07-09 2024-12-18 Jiangsu Hengrui Pharmaceuticals Co., Ltd. SALT TYPES OF A TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CO4410190A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
CN1254280A (zh) 1997-04-30 2000-05-24 伊莱利利公司 用于制备取代的苯并[b]噻吩的区域选择性烷基化方法
AU2003266940B2 (en) 2002-09-30 2007-02-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
WO2008000418A2 (en) * 2006-06-27 2008-01-03 Sandoz Ag New method for salt preparation
WO2008047105A1 (en) * 2006-10-17 2008-04-24 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy

Also Published As

Publication number Publication date
WO2014135834A1 (en) 2014-09-12
WO2014135834A8 (en) 2014-11-27
ZA201401636B (en) 2014-11-26

Similar Documents

Publication Publication Date Title
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
PH12018500591B1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
CL2015002628A1 (es) Compuestos de heteroarilo y sus usos.
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12017500660A1 (en) Novel compositions, uses and methods for making them
MX2016006891A (es) Metodos utiles en la sintesis de analogos de halicondrina b.
PH12015501609A1 (en) Phenicol antibacterials
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
TW201613864A (en) Novel compounds
PH12018500504A1 (en) Compounds useful for inhibiting ror-gamma-t
IN2013MU03862A (instruction)
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
IN2013MU00665A (instruction)
IN2015DN02109A (instruction)
PH12014501313A1 (en) Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
PL3004058T3 (pl) Związki-inhibitory acetylcholinesterazy i agoniści receptorów serotoninergicznych 5ht4, o działaniu propamięciowym, ich sposoby wytwarzania i zawierające je kompozycje farmaceutyczne
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
IN2013MU02010A (instruction)
IN2013MU01524A (instruction)